Viewing Study NCT05466734


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-01-24 @ 5:25 PM
Study NCT ID: NCT05466734
Status: COMPLETED
Last Update Posted: 2023-04-13
First Post: 2022-07-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: BE Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Sponsor: Genovate Biotechnology Co., Ltd.,
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Intermittent Claudication View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Peripheral Artery Disease View
None Cilostazol View
None PMR View
None Extended-Release Tablet of Cilostazol View